Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma
将MCL-1抑制剂与CD37靶向嵌合抗原受体T细胞相结合,是治疗T细胞淋巴瘤的有效策略。
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02697-1
Heavican-Foral, Tayla B; Korell, Felix; Scarfò, Irene; Wiggers, Caroline R M; B, Allen Thayakumar; Eisenbies, Zachary; Powers, Foster; Hegel, Justin; Liu, Jianlin; Kulp, Steffen; Silva, Harrison; Wu, Gongwei; Letai, Anthony; Stegmaier, Kimberly; Lohr, Jens G; Weinstock, David M; Maus, Marcela V; Knoechel, Birgit
T细胞
信号转导
淋巴瘤
CD3
T细胞
CD37
细胞生物学
免疫/内分泌